Antibodies

Antibodies

Primary Antibodies

ETS1

HIF 2 ALPHA

TCEB1

TCEB2

TGF BETA 1

Human

Mouse

WB

FC

IF

IHC

Rabbit

Unconjugated

IgG1

IgG

IgG2b

IgG2a

Ig

IgG1, kappa

IgG2, alpha

Polyclonal

Druggable Genome

ES Cell Differentiation/IPS

Protein Kinase

Transcription Factors

Secreted Protein

Phosphatase

Pathways in cancer

Cell cycle

MAPK signaling pathway

Chronic myeloid leukemia

Wnt signaling pathway

TGF-beta signaling pathway

Colorectal cancer

Prostate cancer

Small cell lung cancer

Thyroid cancer

Bladder cancer

Endometrial cancer

Huntington's disease

Metabolic pathways

Maturity onset diabetes of the young

Melanoma

Ubiquitin mediated proteolysis

Acute myeloid leukemia

Pancreatic cancer

Purine metabolism

Pyrimidine metabolism

RNA polymerase

Renal cell carcinoma

Adipocytokine signaling pathway

Amyotrophic lateral sclerosis (ALS)

Apoptosis

Basal cell carcinoma

Glioma

Jak-STAT signaling pathway

Non-small cell lung cancer

Notch signaling pathway

RNA degradation

Adherens junction

Alzheimer's disease

Cytokine-cytokine receptor interaction

DNA replication

ErbB signaling pathway

Melanogenesis

Neurotrophin signaling pathway

Nucleotide excision repair

Oocyte meiosis

PPAR signaling pathway

p53 signaling pathway

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

Dorso-ventral axis formation

Ribosome

Tight junction

Antigen processing and presentation

Basal transcription factors

Circadian rhythm - mammal

Cysteine and methionine metabolism

Dilated cardiomyopathy

Endocytosis

Focal adhesion

GnRH signaling pathway

Hypertrophic cardiomyopathy (HCM)

Insulin signaling pathway

Leukocyte transendothelial migration

Long-term depression

Long-term potentiation

Lysine degradation

Pathogenic Escherichia coli infection

Primary immunodeficiency

Progesterone-mediated oocyte maturation

Regulation of actin cytoskeleton

Spliceosome

Valine

leucine and isoleucine degradation

mTOR signaling pathway

2

Yes